Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

$688 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMAB I Mab	$320M	$90,000 0.0% of portfolio	37,537	Q2 2025 New
IGMS Igm Biosciences, Inc.	$37.7M	$89,000 0.0% of portfolio	80,311	Q2 2025 Added 218.95%
HOWL Werewolf Therapeutics, Inc.	$35.4M	$86,000 0.0% of portfolio	79,602	Q2 2025 Added 61.33%
GBIO Generation Bio Co.	$239M	$79,000 0.0% of portfolio	249,277	Q2 2025 Added 170.22%
OVID Ovid Therapeutics Inc.	$38.7M	$75,000 0.0% of portfolio	230,245	Q2 2025 Added 177.12%
CLSD Clearside Biomedical, Inc.	$25.9M	$71,000 0.0% of portfolio	89,620	Q2 2025 Added 170.19%
PROK Prokidney Corp Ord Shs Cl A(Cy	$159M	$71,000 0.0% of portfolio	121,323	Q2 2025 Reduced 11.44%
ALXO Alx Oncology Holdings Inc	$25.3M	$68,000 0.0% of portfolio	163,813	Q2 2025 Added 34.59%
DYAI Dyadic International Inc	$24.2M	$68,000 0.0% of portfolio	68,929	Q2 2025 Reduced 17.57%
ANIX Anixa Biosciences Inc	$93.2M	$55,000 0.0% of portfolio	16,803	Q2 2025 Reduced 91.39%
CLLS Cellectis S.A.	$121M	$52,000 0.0% of portfolio	34,433	Q2 2025 New
ANTX An2 Therapeutics, Inc.	$20.6M	$48,000 0.0% of portfolio	45,320	Q2 2025 New
PMVP Pmv Pharmaceuticals, Inc.	$64.8M	$47,000 0.0% of portfolio	44,758	Q2 2025 New
INMB Inmune Bio, Inc.	$43.4M	$46,000 0.0% of portfolio	19,945	Q2 2025 Reduced 50.5%
PEPG Pep Gen Inc.	$28.8M	$46,000 0.0% of portfolio	42,305	Q2 2025 Reduced 44.05%
RLMD Relmada Therapeutics, Inc.	$16.9M	$39,000 0.0% of portfolio	65,803	Q2 2025 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$9.2M	$36,000 0.0% of portfolio	96,909	Q2 2025 Reduced 58.13%
ACXP Acurx Pharmaceuticals, Inc.	$51.2M	$35,000 0.0% of portfolio	69,745	Q2 2025 New
CGEN Compugen LTD	$127M	$35,000 0.0% of portfolio	19,839	Q2 2025 Added 28.04%
PRLD Prelude Therapeutics Inc	$30.6M	$32,000 0.0% of portfolio	39,977	Q2 2025 Reduced 48.66%
BMEA Biomea Fusion, Inc.	$48.3M	$31,000 0.0% of portfolio	17,414	Q2 2025 Reduced 66.15%
PMCB Pharma Cyte Biotech, Inc.	$17.4M	$30,000 0.0% of portfolio	27,606	Q2 2025 Added 49.98%
BCAB Bio Atla, Inc.	$13.4M	$29,000 0.0% of portfolio	74,823	Q2 2025 Added 121.94%
ATHA Athira Pharma, Inc.	$14.4M	$24,000 0.0% of portfolio	80,524	Q2 2025 Added 329.39%
HLVX Hille Vax, Inc.	$69.5M	$23,000 0.0% of portfolio	11,606	Q2 2025 Reduced 74.28%
IKNA Ikena Oncology, Inc.	$50M	$17,000 0.0% of portfolio	13,141	Q2 2025 New
PDSB Pds Biotechnology Corp	$35M	$17,000 0.0% of portfolio	13,407	Q2 2025 Reduced 47.94%
OCUP Ocuphire Pharma, Inc.	$20.2M	$16,000 0.0% of portfolio	17,303	Q2 2025 Reduced 25.09%
NXTC Next Cure, Inc.	$134M	$13,000 0.0% of portfolio	29,503	Q2 2025 New
ADAP Adaptimmune Therapeutics PLC	$13.1M	$10,000 0.0% of portfolio	41,785	Q2 2025 Added 140.92%
RLYB Rallybio Corp	$16.1M	$7,000 0.0% of portfolio	23,263	Q2 2025 New
EQ Equillium, Inc.	$31.9M	$4,000 0.0% of portfolio	15,097	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	256,966	Q2 2025 Added 25.84%
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 0.0% of portfolio	10,723	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.